Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000253285 | SCV000306635 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000253285 | SCV000538219 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Labcorp Genetics |
RCV001522651 | SCV001732236 | benign | Spondyloenchondrodysplasia with immune dysregulation | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001522651 | SCV001768967 | benign | Spondyloenchondrodysplasia with immune dysregulation | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651151 | SCV001864451 | benign | not provided | 2018-11-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000253285 | SCV004234057 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 24% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001651151 | SCV005314660 | benign | not provided | criteria provided, single submitter | not provided |